Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recurrence × X-Rays × CNS × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioma 10 Neuroblastoma 8 Wilms Tumor 7 Osteosarcoma 7 Lymphoma, Non-Hodgkin 7 Hepatoblastoma 7 Rhabdoid Tumor 6 Neuroectodermal Tumors, Primitive, Peripheral 6 Medulloblastoma 6 Histiocytosis, Langerhans-Cell 6 Ependymoma 6 Sarcoma 5 Rhabdomyosarcoma 5 Central Nervous System Neoplasms 5 Sarcoma, Ewing 4 Brain Neoplasms 4 Gliosarcoma 2 Glioblastoma 2 Xanthogranuloma, Juvenile 1 Urinary Bladder Neoplasms 1 Recurrence 1 Ovarian Neoplasms 1 Neurofibrosarcoma 1 Neurofibromatosis 1 1 Meningioma 1 Melanoma 1 Lymphoma 1 Lung Neoplasms 1 Histiocytic Sarcoma 1 Familial ependymoma 1

Interventions

Temozolomide 21 Bevacizumab 18 Cyclophosphamide 7 Lomustine 6 Irinotecan 6 3-Iodobenzylguanidine 6 Topotecan 5 Radiotherapy 4 Radiosurgery 4 Nivolumab 4 Filgrastim 4 Everolimus 4 Carboplatin 4 fludarabine phosphate 3 Vincristine 3 Sirolimus 3 IL13-PE38 3 Etoposide 3 Drug Therapy 3 Busulfan 3 Antilymphocyte Serum 3 thymoglobulin 2 sonidegib 2 ribociclib 2 pembrolizumab 2 paclitaxel-Angiopep-2 conjugate 2 olaparib 2 fluorodopa F 18 2 fludarabine 2 avapritinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02636634 2016-04-11

CV-METANEC

Assistance Publique - Hôpitaux de Paris

Phase 3 Completed

Brain Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡